Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (261-270 of 1,367) with videos related to

Pageof 137
Sort By:
Ejhaem|July 14, 2025
Real-World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective StudyCaroline Piatek, Irina Murakhovskaya, Alia Karaouni, et al.
Ejhaem|January 21, 2026
Cytogenomic Abnormalities in Children With Acute Lymphoblastic Leukemia From Western Mexico: A Single-Center Fluorescence In Situ Hybridization-Based StudyRosa María González Arreola, María Teresa Magaña Torres, Ma Guadalupe Domínguez Quezada, et al.
Ejhaem|February 13, 2025
Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without TransfusionEllen Marin, Aseala Abousaud, Kathleen Davis, et al.
Ejhaem|December 18, 2024
Enteropathy-associated T-cell lymphoma: A population-based cohort study on incidence, treatment, and outcome in the NetherlandsFrederik O Meeuwes, Mirian Brink, Wouter J Plattel, et al.
Ejhaem|December 18, 2024
The prognostic impact of C-reactive protein and albumin in patients diagnosed with acute myeloid leukaemiaEspen Talseth Skar, Øystein Wendelbo, Håkon Reikvam
Ejhaem|December 18, 2024
Safety and efficacy of ketamine use in patients with vaso-occlusive crisis: A systematic review and meta-analysisErnesto Calderon Martinez, Stephin Zachariah Saji, Thomas Campos Carmona, et al.
Ejhaem|December 18, 2024
Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL-specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphomaLaurie Eliason, Fatoumata Fofana, Lin Wang, et al.
Ejhaem|December 18, 2024
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG reportJasmine Naru, Megan Othus, ChenWei Lin, et al.
Ejhaem|December 18, 2024
Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myelomaMarcus Marable, Kaitlin Kelly, Jennifer H Cooperrider, et al.
Ejhaem|December 18, 2024
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health ServiceRakesh Popat, Supratik Basu, Sarah Henshaw, et al.
Pageof 137

Showing results (261-270 of 1,367) with videos related to

Sort By:
Pageof 137
Ejhaem|July 14, 2025
Real-World Use of Rituximab in the Treatment of Cold Agglutinin Disease in the United States: A Retrospective StudyCaroline Piatek, Irina Murakhovskaya, Alia Karaouni, et al.
Ejhaem|January 21, 2026
Cytogenomic Abnormalities in Children With Acute Lymphoblastic Leukemia From Western Mexico: A Single-Center Fluorescence In Situ Hybridization-Based StudyRosa María González Arreola, María Teresa Magaña Torres, Ma Guadalupe Domínguez Quezada, et al.
Ejhaem|February 13, 2025
Hodgkin Lymphoma Treatment With Brentuximab Vedotin in a Patient With HIV, Liver Failure, and Anemia Without TransfusionEllen Marin, Aseala Abousaud, Kathleen Davis, et al.
Ejhaem|December 18, 2024
Enteropathy-associated T-cell lymphoma: A population-based cohort study on incidence, treatment, and outcome in the NetherlandsFrederik O Meeuwes, Mirian Brink, Wouter J Plattel, et al.
Ejhaem|December 18, 2024
The prognostic impact of C-reactive protein and albumin in patients diagnosed with acute myeloid leukaemiaEspen Talseth Skar, Øystein Wendelbo, Håkon Reikvam
Ejhaem|December 18, 2024
Safety and efficacy of ketamine use in patients with vaso-occlusive crisis: A systematic review and meta-analysisErnesto Calderon Martinez, Stephin Zachariah Saji, Thomas Campos Carmona, et al.
Ejhaem|December 18, 2024
Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL-specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphomaLaurie Eliason, Fatoumata Fofana, Lin Wang, et al.
Ejhaem|December 18, 2024
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG reportJasmine Naru, Megan Othus, ChenWei Lin, et al.
Ejhaem|December 18, 2024
Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myelomaMarcus Marable, Kaitlin Kelly, Jennifer H Cooperrider, et al.
Ejhaem|December 18, 2024
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health ServiceRakesh Popat, Supratik Basu, Sarah Henshaw, et al.
Pageof 137